Nahed Nasser Eid El-Sayed
Egyptian Drug Authority, College of Science, King Saud University, Women Students-Medical Studies & Sciences sections
Research areas: Chemistry · Organic Chemistry · Synthesis and biological activity · Synthesis and Characterization of Heterocyclic Compounds · Computational Drug Discovery Methods
0000-0001-9771-8956
About
Nahed Nasser Eid El-Sayed, B.Sc. Biochemistry with Chemistry and M.Sc. in Organic Chemistry, Faculty of Science, Ain Shams University, Cairo, Egypt. PhD. in Synthetics Organic Chemistry (2006), School of Chemistry, Cardiff University, UK. Assistant Professor and Associate Professor of Organic Chemistry (2009-2019), Department of Chemistry, King Saud University, Riyadh, Saudi Arabia.
Researcher and Associate Research Professor of Organic Chemistry, Egyptian Drug Authority (2007-2009 and 2022 till date, respectively).
Employment
-
Egyptian Drug Authority Associate Research Professor2022 - Present
-
College of Science, King Saud University, Women Students-Medical Studies & Sciences sections Associate Professor of Organic Chemistry2017 - 2019
-
College of Science, King Saud University, Women Students-Medical Studies & Sciences sections Assistant Professor of Organic Chemistry2009 - 2017
Education
Education history is unavailable.
Projects & Funding
-
Chemistry The Research Group Program (RGP) - Vice Rectorate for Graduate Studies and Scientific Research, Deanship of Scientific Research2014 - 2015
-
Chemistry Vice Rectorate for Graduate Studies and Scientific Research, Deanship of Scientific Research2014 - 2015
Publications (50)
- Synthesis and Anticancer Activity of New Quinazolin-4(3H)-one Derivatives: Identification of a Tumor-Selective Anticancer Agent with Potential Inhibition of TGF-βRI (ALK5) Save
- Identification of novel thiazolyl-1,2,3-triazole hybrids as potent VEGFR-2 inhibitors for breast cancer treatment Save
- Quinolone as a Privileged Scaffold: A Brief Overview on Early Classical and Recent Advanced Synthetic Pathways, Innovative Neuroprotective Potential, and Structure‐Activity Relationships Save
- 6,7-Dimethoxy-2-methyl-4-substituted quinazolines: Design, synthesis, EGFR inhibitory activity, in vitro cytotoxicity, and in silico studies Save
- New Nitrogen-, Oxygen-, and Sulfur-Containing Heterocyclic Compounds as Anti-Colon Cancer Agents: Synthesis, Multitargeted Evaluations, Molecular Docking Simulations and ADMET Predictions Save
- Leveraging nitrogen occurrence in approved drugs to identify structural patterns Save
- Discovery of novel quinolin-2-one derivatives as potential GSK-3 β inhibitors for treatment of Alzheimer ' s disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation Save
- Synthesis and Biological Evaluation of Some New 3-Aryl-2-thioxo-2,3-dihydroquinazolin-4(1H)-ones and 3-Aryl-2-(benzylthio)quinazolin-4(3H)-ones as Antioxidants; COX-2, LDHA, α-Glucosidase and α-Amylase Inhibitors; and Anti-Colon Carcinoma and Apoptosis-I… Save
- Synthesis and Evaluation of Some New 4H-Pyran Derivatives as Antioxidant, Antibacterial and Anti-HCT-116 Cells of CRC, with Molecular Docking, Antiproliferative, Apoptotic and ADME Investigations Save
- Biological Evaluation, Molecular Docking Analyses, and ADME Profiling of Certain New Quinazolinones as Anti-colorectal Agents Save
- Synthesis and Characterization of Some New Quinoxalin-2(1H)one and 2-Methyl-3H-quinazolin-4-one Derivatives Targeting the Onset and Progression of CRC with SRA, Molecular Docking, and ADMET Analyses Save
- Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis Save
- Balanced QSAR analysis to identify the structural requirements of ABBV-075 (Mivebresib) analogues as bromodomain and extraterminal domain (BET) family bromodomain inhibitor Save
- Evaluation of the in vitro anti-inflammatory and cytotoxic potential of ethanolic and aqueous extracts of Origanum syriacum and Salvia lanigera leaves Save
- Synthesis, Biological, and Molecular Docking Studies on 4,5,6,7-Tetrahydrobenzo[ b]thiophene Derivatives and Their Nanoparticles Targeting Colorectal Cancer Save
- Synthesis of antimicrobial agents of tetra‐substituted thiophenes from ethyl 5‐(2‐bromoacetyl)‐4‐phenyl‐2‐(phenylamino)thiophene‐3‐carboxylate Save
- Identification of prodigious and under-privileged structural features for RG7834 analogs as Hepatitis B virus expression inhibitor Save
- Synthesis and evaluation of anticancer, antiphospholipases, antiproteases, and antimetabolic syndrome activities of some 3H-quinazolin-4-one derivatives Save
- Multiple quantitative structure-activity relationships (QSARs) analysis for orally active trypanocidal N-myristoyltransferase inhibitors Save
- Quinoxalinones Based Aldose Reductase Inhibitors: 2D and 3D-QSAR Analysis Save